10-Q: Amesite Inc. Reports Q2 2025 Results, Revenue Declines Amid Strategic Shift

Amesite Inc. reports a decrease in revenue for the six months ended December 31, 2024, alongside a strategic pivot to grow its customer base and reduce losses.

Summary

• Amesite Inc. reported its financial results for the quarter ended December 31, 2024.
• The company is focused on developing B2C and B2B AI-driven solutions, including a higher ed platform and healthcare app.
• Net revenue for the six months ended December 31, 2024, was $24,010, compared to $104,776 for the same period in 2023.
• The company experienced a net loss of $2,029,682 for the six months ended December 31, 2024, compared to a net loss of $1,796,304 for the same period in 2023.
• Operating expenses decreased from $2,010,850 to $2,082,223.
• As of December 31, 2024, cash and cash equivalents totaled $519,706.
• The company has a history of net losses and negative cash flows and expects to continue incurring losses.
• Management believes it may not have sufficient cash to maintain planned operations for the next twelve months.
• The company plans to generate cash through financing transactions, including offerings of common stock.
• Amesite received a Nasdaq deficiency letter due to not meeting the minimum stockholders' equity requirement, but submitted a plan to regain compliance and believes it has regained compliance due to a January 2025 public offering.
• The company identified material weaknesses in its internal controls related to journal entries, stock compensation, and deferred revenue.

Sentiment

Score: 3

Explanation: The document presents a concerning financial picture with declining revenue, increasing losses, and a going concern warning. While the company is taking steps to address these issues, the overall sentiment is negative.

Positives

• Amesite is focusing on AI-driven solutions, which could be a growth area.
• The company is taking steps to address material weaknesses in internal controls.
• Sales and marketing expenses decreased due to refinement of processes.
• The company believes it has regained compliance with Nasdaq listing requirements after a public offering.

Negatives

• Revenue decreased significantly for the six months ended December 31, 2024.
• The company continues to experience net losses and negative cash flows.
• There is substantial doubt about the company's ability to continue as a going concern.
• The company identified material weaknesses in its internal controls over financial reporting.
• Amesite received a Nasdaq deficiency letter for not meeting the minimum stockholders' equity requirement.

Risks

• The company's ability to continue as a going concern is uncertain.
• The company's plans to generate cash through financing transactions are subject to market conditions and are not within the company's control.
• Failure to maintain compliance with Nasdaq listing requirements could result in delisting.
• The company has not developed a strong customer base and has not generated sustainable revenue since inception.
• The company's stock price is volatile.
• Material weaknesses in internal controls could lead to misstatements in financial reporting.

Future Outlook

Management believes that it may not have sufficient cash and cash equivalents to maintain the Company's planned operations for the next twelve months following the issuance of these condensed financial statements and plans to generate cash by completing financing transactions, which may include offerings of common stock.

Management Comments

• Management believes that AI-powered learning programs, priced affordably, will supplant other academic products in the mid to long term.
• The incremental cost to Amesite in delivering the academic platform is de minimis, as the system is turnkey, and the technology stack is robust.
• The company has focused all new development work on delivering AI tools to markets hungry for increased capability that immediately impacts both their performance and their bottom line.

Industry Context

Amesite is operating in the rapidly evolving technology sector, specifically focusing on AI-driven solutions for education and healthcare. The company's strategic shift reflects a response to challenges in securing larger, upfront deals and a move towards more sustainable revenue models, such as fee-per-course offerings and AI tools for specific markets.

Comparison to Industry Standards

• It's difficult to directly compare Amesite's results to industry standards without knowing the specific sub-sectors and target markets.
• However, the company's focus on AI in education and healthcare aligns with broader industry trends.
• Companies like Coursera and 2U in the online education space, and various healthcare technology companies, are also investing in AI to enhance their offerings.
• Amesite's revenue decline and net losses are concerning, especially compared to more established players in these sectors.
• The company's ability to secure additional funding and demonstrate sustainable growth will be crucial for its long-term success.

Stakeholder Impact

• Shareholders face the risk of further stock dilution through potential future offerings.
• Employees face uncertainty due to the company's financial instability.
• Customers may be concerned about the company's ability to provide ongoing services and support.
• Creditors face increased risk of non-payment due to the company's financial difficulties.

Next Steps

• The company intends to take all reasonable measures available to maintain compliance under the Nasdaq Listing Rules and remain listed on Nasdaq.
• The Company will take steps to remediate the material weaknesses through the documentation of processes and controls for transactions that occur in the course of business, and in the financial statement close, reporting and disclosure processes.
• The Company will formalize our process and documentation for monitoring internal control over financial reporting.

Key Dates